Web Analytics

3 Latest Announced Rounds

  • $23,000,000
    Series B

    1 Investors

    Medical Device
    May 30th, 2025
  • $4,000,000
    Seed

    2 Investors

    Information Technology & Services
    May 30th, 2025
  • $10,000,000
    Series A

    3 Investors

    Financial Services
    May 30th, 2025
$545.74M Raised in 54 Funding Rounds in the past 7 Days - View All

Funding Round Profile

DalCor Pharmaceuticals

start up
Canada - Montreal, Québec
  • 22/09/2023
  • Series D
  • $80,000,000

DalCor Pharmaceuticals: DalCor Pharmaceuticals is pioneering precision medicine for patients with cardiovascular disease. By combining genetic and clinical insights, the company’s development program, dalcetrapib, is intended to reduce fatal and non-fatal myocardial infarction (MI) following a recent acute coronary syndrome and deliver superior cardiovascular outcome in a specific genetic subset of patients.


Related People